Company Overview and News

0
Keep ThyssenKrupp whole, German minister urges

17m channelnewsasia
German Labor Minister Hubertus Heil said he was increasingly concerned about the situation at submarines-to-elevators conglomerate ThyssenKrupp after it lost its top officials under pressure from shareholders to restructure.
500470 TTST TATASTEEL TATLY

0
UPDATE 1-EU to curb steel imports after Trump tariffs

28m reuters
BRUSSELS (Reuters) - The European Union will launch measures on Thursday designed to prevent a surge of steel imports into the bloc following the U.S. imposition of tariffs on incoming steel and aluminum, the EU’s official journal said.
500470 TTST TATASTEEL TATLY

0
Keep ThyssenKrupp whole, German minister urges

40m reuters
BERLIN (Reuters) - German Labor Minister Hubertus Heil said he was increasingly concerned about the situation at submarines-to-elevators conglomerate ThyssenKrupp (TKAG.DE) after it lost its top officials under pressure from shareholders to restructure.
500470 TTST TATASTEEL TATLY

3
How Tata Steel is reversing its sunk cost fallacy

2h moneycontrol
The world’s most astute investor and businessman Warren Buffett once admitted to losing a huge sum of money letting sunk cost fallacy (infusing more and more capital to salvage an original investment) play out by keeping alive the loss-making textile business of Berkshire Hathaway. He eventually rectified the mistake and gradually moved capital to more profitable and viable businesses.
BRK.A 500470 TTST TATASTEEL TATLY 500228 JSWSTEEL

3
For most companies, investors have little say in ratifying auditors

7h livemint
Bengaluru: More than half of the 161 companies that have held their annual meetings this year, including Reliance Industries Ltd (RIL) and Tata Steel Ltd, did not seek shareholders’ approval for ratification of auditors.
YESBANK 500325 AXB RELIANCE 532648 YYBKY 532215 AXBKY AXBA WIT 500470 TTST TATASTEEL TATLY HDB AXISBANK 500180 RIGD HDFCBANK RLNIY

0
Thyssenkrupp inches toward breakup as top leadership departs

22h livemint
Frankfurt: After losing its top leadership in less than two weeks, it’s looking more likely that Thyssenkrupp AG could be headed for a breakup, although much rests on the next move of the company’s largest shareholder.
500470 TTST TATASTEEL TATLY

0
NCLAT stops Bhushan Power Steel lenders from voting on Tata Steel bid

2018-07-17 moneycontrol
The National Company Law Appellate Tribunal on Tuesday stopped the lenders of Bhushan Power & Steel from voting on the resolution plan submitted by Tata Steel.
500470 TTST TATASTEEL TATLY 500228 JSWSTEEL

0
Thyssenkrupp leadership vacuum revives restructuring hopes

2018-07-17 theedgemarkets
FRANKFURT (July 17): Thyssenkrupp shares were indicated 3.4% higher early on Tuesday as analysts expect a deeper restructuring of the German submarines-to-elevators conglomerate after the resignation of its chairman.
500470 TTST TATASTEEL TATLY

0
Thyssenkrupp leadership vacuum revives restructuring hopes

2018-07-17 reuters
FRANKFURT (Reuters) - Thyssenkrupp (TKAG.DE) shares were indicated 3.4 percent higher early on Tuesday as analysts expect a deeper restructuring of the German submarines-to-elevators conglomerate after the resignation of its chairman.
500470 TTST TATASTEEL TATLY

0
Tata Steel plans to raise around $3.1 billion through overseas loans

2018-07-17 moneycontrol
Tata Steel may raise around USD 3.1 billion through overseas loans to repay existing debt, ahead of the merger of its European operations with Thyssenkrupp, according to a report by The Economic Times.
500470 TTST TATASTEEL TATLY

0
Thyssenkrupp leadership vacuum revives restructuring hopes

2018-07-17 channelnewsasia
FRANKFURT: Thyssenkrupp shares were indicated 3.4 percent higher early on Tuesday as analysts expect a deeper restructuring of the German submarines-to-elevators conglomerate after the resignation of its chairman.
500470 TTST TATASTEEL TATLY

4
Sensex rises over 100 points after sharp fall in crude prices

2018-07-17 freepressjournal.in
Mumbai: The BSE Sensex recovered over 107 points to 36,431.17 in early trade today on fresh buying by investors after a sharp drop on global crude oil prices and a strengthening rupee.
YESBANK IBN HINDUNILVR 532648 YYBKY VEDL ICICIBANK 500470 TTST TATASTEEL TATLY 532174 500696 500570 TATAMOTORS TTM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...